The NHS National Centre for Neurotechnology and Neurorestoration is the UK’s first centre dedicated to support new and emerging technologies interacting with the brain or nervous system.
This is critical as neurological conditions are the leading cause of global disease burden and are increasing at an accelerating rate. Management of these conditions present one of the greatest challenges facing healthcare in the future. As neurotechnologies and artificial intelligence evolve rapidly, we are entering a new era in our understanding and treatment of the human brain.
The centre has a specific mission to accelerate the use, certification, and adoption of neurotechnologies and provides dedicated end-to-end infrastructure and expertise to deliver the potential of neurotechnologies.
Neurotechnologies include state-of-the-art devices such as brain-computer interfaces and brain stimulators. These devices offer transformative change to the management of neurological conditions where there are currently limited, or no treatment options available, for example, in motor, sensory, cognitive or mood disorders.
Devices vary in their placement and can be either implanted or non-implanted. Implanted devices are located intracranially or within brain tissue, whereas non-implanted devices are positioned externally and do not require surgical intervention. The centre supports all neurotechnologies with specific processes for different device types. If a surgical procedure is required, the centre has unique clinical capacity and expertise for these procedures.
Examples of neurotechnologies include:
Investigating, delivering and maximising the potential of neurotechnology to improve health requires unique clinical understanding, capability and skills to ensure safe, appropriate and effective use at the forefront of innovation.
At our centre, we’re leading scientific research, innovation and treatment in neurotechnology. We’re a dedicated UK hub, bringing together partners in the UK and across the world to ensure advances are made available to patients who would benefit.
This early access to new and emerging technologies, allows thorough research and evaluation of the latest available technologies designed to improve our understanding of the human brain, health outcomes and quality of life.
All trials are established and conducted in accordance with appropriate regulatory, legal and clinical governance frameworks.
